Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Arginine Supplementation in Sickle Cell Anemia
NCT00513617Phase 2Completed
- Sponsor
- UCSF Benioff Children's Hospital Oakland
- Start
- Jun 2004
- Primary completion
- Sep 2007
- Modality
- Peptides, Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of arginine in sickle cell anemia (SCA), sponsored by UCSF Benioff Children's Hospital Oakland. Started Jun 2004; status: completed.
02
Drugs
arginine
03
Conditions
sickle cell anemia (SCA)
Beyond the preview
Go deeper on NCT00513617.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00513617.